Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Blanco

Showing results (501-510 of 530) with videos related to

Pageof 53
Sort By:
Clinical Drug Investigation|May 21, 2011
Clinical utility of maravirocJorge Parra, Joaquín Portilla, Federico Pulido, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2023
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life settingAlba Rocabert, Beatriz Borjabad, Leire Berrocal, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension studyBeatriz Borjabad, Jhon Rojas, Alexy Inciarte, et al.
The Journal of Biological Chemistry|October 2, 2001
Eukaryotic DNA polymerases: proposal for a revised nomenclatureP M Burgers, E V Koonin, E Bruford, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
The Journal of Clinical Investigation|September 22, 2022
Neonatal hyperoxia in mice triggers long-term cognitive deficits via impairments in cerebrovascular function and neurogenesisMarissa A Lithopoulos, Xavier Toussay, Shumei Zhong, et al.
Infectious Diseases and Therapy|July 26, 2023
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective StudyLorena De La Mora, Cristina Pitart, Laura Morata, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 29, 2001
[GESIDA Consensus document on the use of resistance studies in clinical practice]J M Gatell, J L Blanco, J Alcamí, et al.
AIDS (London, England)|January 11, 2022
Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infectionsElisa de Lazzari, Alejandra Martínez-Mimbrero, Iván Chivite, et al.
Pageof 53

Showing results (501-510 of 530) with videos related to

Sort By:
Pageof 53
Clinical Drug Investigation|May 21, 2011
Clinical utility of maravirocJorge Parra, Joaquín Portilla, Federico Pulido, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2023
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life settingAlba Rocabert, Beatriz Borjabad, Leire Berrocal, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension studyBeatriz Borjabad, Jhon Rojas, Alexy Inciarte, et al.
The Journal of Biological Chemistry|October 2, 2001
Eukaryotic DNA polymerases: proposal for a revised nomenclatureP M Burgers, E V Koonin, E Bruford, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
The Journal of Clinical Investigation|September 22, 2022
Neonatal hyperoxia in mice triggers long-term cognitive deficits via impairments in cerebrovascular function and neurogenesisMarissa A Lithopoulos, Xavier Toussay, Shumei Zhong, et al.
Infectious Diseases and Therapy|July 26, 2023
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective StudyLorena De La Mora, Cristina Pitart, Laura Morata, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 29, 2001
[GESIDA Consensus document on the use of resistance studies in clinical practice]J M Gatell, J L Blanco, J Alcamí, et al.
AIDS (London, England)|January 11, 2022
Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infectionsElisa de Lazzari, Alejandra Martínez-Mimbrero, Iván Chivite, et al.
Pageof 53